Developing a Vaccine that Protects Against Covid-19 Variants
Despite the promise of several approved Covid-19 vaccines and the widespread rollout of vaccination programs…
The Covid-19 pandemic began as a few scattered cases in China, but within months, the respiratory infection had swept the world. The years 2020 and 2021 turned into a rollercoaster ride for the world’s population, with millions of people dead, livelihoods destroyed, and movement between countries plummeting.
Despite the strained situation, academic researchers and biotech and pharma companies globally have come together to develop protective vaccines and treatments against Covid-19. While we still have a long road ahead before this pandemic is declared over, the life sciences industry is bringing us closer to this moment with every new discovery, trial result, and fundraise. Read on to learn about the latest research, investments, trends, and pipeline developments.
European Biotech Industry Report 2021: A Year of European Biotechnology
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations in the biotech and pharma industry.
Go to ReportDespite the promise of several approved Covid-19 vaccines and the widespread rollout of vaccination programs…
The Covid-19 pandemic exposed the weaknesses in our defenses. Vaccine platforms will be a powerful…
As AstraZeneca and the University of Oxford’s Covid-19 vaccine debuts in the EU market this…
DNA synthesis is one of the pillars of Covid-19 research that has suffered supply disruptions…
Since the debut of Imlygic in 2015, no other oncolytic virus cancer therapies have been…
The global Covid-19 pandemic has forced us to put our lives on hold, and a…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
BioNTech and Pfizer’s Covid-19 vaccine, made from messenger RNA, has become the first of its…
Companies developing vaccines, drugs, and diagnostics for Covid-19 are being forced to scale up manufacturing…
A much anticipated Covid-19 vaccine, developed by the University of Oxford and AstraZeneca, achieved 70%…
Hospital facilities in Europe are being pushed to their limits as the Covid-19 pandemic continues…
The field of messenger RNA therapeutics is flying high as BioNTech and Pfizer conclude a…